- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 498/14 - Ortho-condensed systems
Patent holdings for IPC class C07D 498/14
Total number of patents in this class: 1056
10-year publication summary
80
|
68
|
77
|
83
|
92
|
102
|
97
|
92
|
86
|
28
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Shionogi & Co., Ltd. | 914 |
66 |
ViiV Healthcare Company | 146 |
28 |
Gilead Sciences, Inc. | 1879 |
26 |
Merck Patent GmbH | 5909 |
19 |
Bayer Pharma AG | 1096 |
19 |
Genentech, Inc. | 3742 |
18 |
Newave Pharmaceutical Inc. | 54 |
18 |
The Regents of the University of Michigan | 4409 |
15 |
Novartis AG | 11238 |
14 |
Bayer AG | 3045 |
14 |
The Broad Institute, Inc. | 1584 |
14 |
G1 Therapeutics, Inc. | 128 |
12 |
Medshine Discovery Inc. | 581 |
12 |
Sunshine Lake Pharma Co., Ltd. | 542 |
12 |
Merck Sharp & Dohme LLC | 3689 |
11 |
Abbvie Inc. | 1808 |
10 |
Janssen Sciences Ireland Unlimited Company | 431 |
10 |
Pro Farm Group, Inc. | 105 |
10 |
F. Hoffmann-La Roche AG | 7958 |
9 |
AstraZeneca AB | 3042 |
9 |
Other owners | 710 |